STAGE IIA LUNG CANCER AJCC V8
Clinical trials for STAGE IIA LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIA LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug stop lung cancer before it starts?
Prevention CompletedThis study tested whether the immunotherapy drug pembrolizumab can prevent lung cancer in 45 people with early-stage non-small cell lung cancer or suspicious lung nodules. Participants received the drug and were monitored for tumor response and survival. The goal was to see if bo…
Matched conditions: STAGE IIA LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated May 12, 2026 13:43 UTC
-
Could a vaccine stop lung cancer before it starts?
Prevention CompletedThis early-phase trial tested a vaccine called CIMAvax-EGF in 20 people at high risk for lung cancer or survivors at risk of recurrence. The vaccine works by helping the body make antibodies against a protein (EGF) that can fuel cancer growth. Researchers measured immune response…
Matched conditions: STAGE IIA LUNG CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Prevention
Last updated May 05, 2026 11:56 UTC
-
Tiny heart monitor spies hidden damage during cancer radiation
Knowledge-focused CompletedThis study involved 24 people with lung or esophageal cancer receiving radiation therapy near the heart. Researchers used a small implanted device to continuously monitor heart activity for up to a year. The goal was to detect early heart changes that might otherwise go unnoticed…
Matched conditions: STAGE IIA LUNG CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC